Literature DB >> 35465885

Surgical Neuro-Oncology: Management of Glioma.

Dana Mitchell1, Jack M Shireman2, Mahua Dey3.   

Abstract

Gliomas are the most common intrinsic brain tumor in adults. Although maximal tumor resection improves survival, this must be balanced with preservation of neurologic function. Technological advancements have greatly expanded our ability to safely maximize tumor resection and design innovative therapeutic trials that take advantage of intracavitary delivery of therapeutic agents after resection. In this article, we review the role of surgical intervention for both low-grade and high-grade gliomas and the innovations that are driving and expanding the role of surgery in this therapeutically challenging group of malignancies.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Astrocytoma; Biopsy; Glioblastoma; Glioma; Low-grade glioma; Management; Oligodendroglioma; Surgery

Mesh:

Year:  2022        PMID: 35465885      PMCID: PMC9048103          DOI: 10.1016/j.ncl.2021.11.003

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.787


  53 in total

Review 1.  Intraoperative MRI developments.

Authors:  Rudolf Fahlbusch; Christopher Nimsky
Journal:  Neurosurg Clin N Am       Date:  2005-01       Impact factor: 2.509

2.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial.

Authors:  Walter Stummer; Uwe Pichlmeier; Thomas Meinel; Otmar Dieter Wiestler; Friedhelm Zanella; Hans-Jürgen Reulen
Journal:  Lancet Oncol       Date:  2006-05       Impact factor: 41.316

Review 3.  Conventional MRI evaluation of gliomas.

Authors:  N Upadhyay; A D Waldman
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

4.  MR imaging correlates of survival in patients with high-grade gliomas.

Authors:  Whitney B Pope; James Sayre; Alla Perlina; J Pablo Villablanca; Paul S Mischel; Timothy F Cloughesy
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

Review 5.  Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas.

Authors:  M J van den Bent; J S Wefel; D Schiff; M J B Taphoorn; K Jaeckle; L Junck; T Armstrong; A Choucair; A D Waldman; T Gorlia; M Chamberlain; B G Baumert; M A Vogelbaum; D R Macdonald; D A Reardon; P Y Wen; S M Chang; A H Jacobs
Journal:  Lancet Oncol       Date:  2011-04-05       Impact factor: 41.316

6.  Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.

Authors:  Gregory Cairncross; Meihua Wang; Edward Shaw; Robert Jenkins; David Brachman; Jan Buckner; Karen Fink; Luis Souhami; Normand Laperriere; Walter Curran; Minesh Mehta
Journal:  J Clin Oncol       Date:  2012-10-15       Impact factor: 44.544

7.  Presurgical functional MR imaging of language and motor functions: validation with intraoperative electrocortical mapping.

Authors:  Alberto Bizzi; Valeria Blasi; Andrea Falini; Paolo Ferroli; Marcello Cadioli; Ugo Danesi; Domenico Aquino; Carlo Marras; Dario Caldiroli; Giovanni Broggi
Journal:  Radiology       Date:  2008-06-06       Impact factor: 11.105

8.  Multiple resections for patients with glioblastoma: prolonging survival.

Authors:  Kaisorn L Chaichana; Patricia Zadnik; Jon D Weingart; Alessandro Olivi; Gary L Gallia; Jaishri Blakeley; Michael Lim; Henry Brem; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2012-10-19       Impact factor: 5.115

9.  Diffusion- and perfusion-weighted MRI radiomics model may predict isocitrate dehydrogenase (IDH) mutation and tumor aggressiveness in diffuse lower grade glioma.

Authors:  Minjae Kim; So Yeong Jung; Ji Eun Park; Yeongheun Jo; Seo Young Park; Soo Jung Nam; Jeong Hoon Kim; Ho Sung Kim
Journal:  Eur Radiol       Date:  2019-12-11       Impact factor: 5.315

10.  Minimally Invasive Resection of Deep-seated High-grade Gliomas Using Tubular Retractors and Exoscopic Visualization.

Authors:  Rajiv Iyer; Kaisorn L Chaichana
Journal:  J Neurol Surg A Cent Eur Neurosurg       Date:  2018-04-23       Impact factor: 1.268

View more
  1 in total

1.  A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas.

Authors:  Peng Ren; Jing-Ya Wang; Zhi-Rui Zeng; Nan-Xi Li; Hong-Lei Chen; Xin-Ge Peng; Ujjal K Bhawal; Wen-Zhi Guo
Journal:  Front Genet       Date:  2022-09-02       Impact factor: 4.772

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.